Sexual state-regulated insulin signaling and vulval epithelial cues engage distinct pathways to remodel the F-actin ...

In an expansion of its previous moves to cut insulin prices, Sanofi will cap the price of each of its insulin products at $35 per month in the U.S. regardless of a patient's insurance status. The move ...

Persistent high blood sugar in diabetes, despite insulin use, often stems from insulin resistance, where cells fail to respond effectively to the hormone. Factors like excess weight, inactivity, ...

The debate about AI’s impact on consulting tends to swing between two extremes: Some argue that AI will render consultants obsolete; others claim it will only make them more indispensable. Both views ...

With Comcast on track to spin off Versant by year end, CFO Jason Armstrong said more details of the standalone linear network company are coming soon and the new entity will enter the world solid and ...

Take control of your health before it’s too late. Detecting insulin resistance early can help you prevent diabetes, heart disease, and more. Start tracking your fasting insulin now and make lifestyle ...

On Friday, August 8, 2025, the Karnataka State Education Policy Commission, chaired by economist and former University Grants Commission (UGC) Chairman Prof Sukhadeo Thorat, submitted its report to ...

Capital structure refers to the mix of funding sources a company uses to finance its assets and its operations. The sources typically can be bucketed into equity and debt. Using internally generated ...

Despite recent legislation capping insulin prices and manufacturer assistance programs, some people with diabetes who require insulin still encounter barriers to obtaining a reliable supply. T1 ...

Picture this: You’re a manager seeking to fill an important position on your team. You’ve shortlisted a few people, but you’re looking for the candidate to give your final rose. Based on their resumes ...

LONDON, Nov 14 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of ...